FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


140498 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Adverse reaction to antibiotic A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antibiotic NOS Limited component (foundation metadata concept)
Adverse reaction to anticholinesterase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anticoagulant antagonist NOS Limited component (foundation metadata concept)
Adverse reaction to anticoagulants A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to anticoagulants NOS Limited component (foundation metadata concept)
Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS Classification derived component
Adverse reaction to anticonvulsants NOS Limited component (foundation metadata concept)
Adverse reaction to anticonvulsants and anti-parkinsonism drugs A component that fails to comply with the current editorial guidance.
Adverse reaction to antidepressant A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antidepressants NOS Limited component (foundation metadata concept)
Adverse reaction to antidiarrheal drug A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antidiarrheal drugs NOS Limited component (foundation metadata concept)
Adverse reaction to antidotes and chelating agents NEC Ambiguous
Adverse reaction to antifungal antibiotics A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antifungal antibiotics A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antifungal antibiotics NOS Limited component (foundation metadata concept)
Adverse reaction to antihelminthic NOS Limited component (foundation metadata concept)
Adverse reaction to antihelminthics A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antihelminthics A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antihypertensives NOS Limited component (foundation metadata concept)
Adverse reaction to antilipemic and anti-arteriosclerotic drugs Ambiguous
Adverse reaction to antilipemic and antiarteriosclerotic drugs NOS Limited component (foundation metadata concept)
Adverse reaction to antilymphocyte immunoglobulin Ambiguous
Adverse reaction to antimalarials A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antimalarials NOS Limited component (foundation metadata concept)
Adverse reaction to antimony compound A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antimycobacterial antibiotic NOS Limited component (foundation metadata concept)
Adverse reaction to antimycobacterial antibiotics A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antimycobacterial drug NOS Limited component (foundation metadata concept)
Adverse reaction to antineoplastic and immunosuppressive drugs A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antineoplastic and immunosuppressive drugs NOS Limited component (foundation metadata concept)
Adverse reaction to antineoplastic antibiotics NOS Limited component (foundation metadata concept)
Adverse reaction to antiparkinsonism drug A component that fails to comply with the current editorial guidance.
Adverse reaction to antiparkinsonism drugs NOS Classification derived component
Adverse reaction to antiprotozoal drug A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiprotozoal drug A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiprotozoal drugs NOS Limited component (foundation metadata concept)
Adverse reaction to antirheumatics NOS Limited component (foundation metadata concept)
Adverse reaction to antithyroid agents A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antithyroid agents NOS Limited component (foundation metadata concept)
Adverse reaction to antitussive NOS Limited component (foundation metadata concept)
Adverse reaction to antitussives A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antivaricose drug A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antivaricose drugs NOS Limited component (foundation metadata concept)
Adverse reaction to antiviral drug NOS Limited component (foundation metadata concept)
Adverse reaction to antiviral drugs A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to antiviral drugs A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to aromatic analgesics NEC Limited component (foundation metadata concept)
Adverse reaction to aromatic analgesics NOS Limited component (foundation metadata concept)
Adverse reaction to aspirin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to aspirin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to atenolol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to atropine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to auranofin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
bivirkning ved avomin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to azathioprine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to azlocillin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bacampicillin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to barbiturate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to barbiturate NOS A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beclamide A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bendrofluazide A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to benzhexol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to benzodiazepine-based tranquilizer (finding) Ambiguous
Adverse reaction to benzodiazepine-based tranquilizer NOS (disorder) Ambiguous
Adverse reaction to benztropine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bephenium A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beta-blockers A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beta-blockers A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to beta-blockers NOS Limited component (foundation metadata concept)
Adverse reaction to betamethasone A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bethanidine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bezafibrate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to biperiden A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bisacodyl A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bismuth compound A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bleomycin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to blood or blood products NOS Limited component (foundation metadata concept)
Adverse reaction to bromine compound A component that is no longer current, useful, appropriate or acceptable.
Adverse reaction to bromine compounds NOS Limited component (foundation metadata concept)
Adverse reaction to bupivacaine hydrochloride A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to buprenorphine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to bupropion A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to busulfan A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to butobarbitone A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to butriptyline A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to butyrophenone-based tranquilizer (finding) Ambiguous
Adverse reaction to butyrophenone-based tranquilizers NOS (disorder) Limited component (foundation metadata concept)
Adverse reaction to calcitonin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to cannabis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to capillary-active drugs NOS Limited component (foundation metadata concept)
Adverse reaction to capreomycin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to captopril A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to carbamate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to carbamazepine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to carbenicillin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to carbimazole A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to carbonic acid anhydrase inhibitor A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to carbonic acid anhydrase inhibitor NOS Limited component (foundation metadata concept)
Adverse reaction to carboplatin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 76 of 1405 Next End


Reference Sets

Reference set descriptor

Back to Start